BPC-157 and TB-500 are often discussed together due to their association with recovery pathways, tissue remodelling, angiogenesis and repair-related biological processes
However, typical research protocols use 250-500mcg once or twice daily, often injected subcutaneously near the injury site
J.SchiergensK
Who Its For Researchers requiring a spray-format delivery vehicle for BPC-157 in mucosal, topical, or intranasal research protocols
In addition, products from such vendors may contain impurities or harmful chemicals, increasing the risk of adverse effects
Common peptides being promoted on social media include BPC-157, TB-500, CJC-1295, Ipamorelin, and various growth hormone releasing peptides